132 related articles for article (PubMed ID: 12524208)
1. Notch, a unifying target in T-cell acute lymphoblastic leukemia?
Screpanti I; Bellavia D; Campese AF; Frati L; Gulino A
Trends Mol Med; 2003 Jan; 9(1):30-5. PubMed ID: 12524208
[TBL] [Abstract][Full Text] [Related]
2. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
3. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells.
Guan E; Wang J; Laborda J; Norcross M; Baeuerle PA; Hoffman T
J Exp Med; 1996 May; 183(5):2025-32. PubMed ID: 8642313
[TBL] [Abstract][Full Text] [Related]
4. Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma.
Talora C; Campese AF; Bellavia D; Pascucci M; Checquolo S; Groppioni M; Frati L; von Boehmer H; Gulino A; Screpanti I
EMBO Rep; 2003 Nov; 4(11):1067-72. PubMed ID: 14566327
[TBL] [Abstract][Full Text] [Related]
5. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
[TBL] [Abstract][Full Text] [Related]
6. PKC theta mediates pre-TCR signaling and contributes to Notch3-induced T-cell leukemia.
Felli MP; Vacca A; Calce A; Bellavia D; Campese AF; Grillo R; Di Giovine M; Checquolo S; Talora C; Palermo R; Di Mario G; Frati L; Gulino A; Screpanti I
Oncogene; 2005 Feb; 24(6):992-1000. PubMed ID: 15592506
[TBL] [Abstract][Full Text] [Related]
7. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling.
Weng AP; Nam Y; Wolfe MS; Pear WS; Griffin JD; Blacklow SC; Aster JC
Mol Cell Biol; 2003 Jan; 23(2):655-64. PubMed ID: 12509463
[TBL] [Abstract][Full Text] [Related]
8. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
10. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
11. Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development.
Felli MP; Maroder M; Mitsiadis TA; Campese AF; Bellavia D; Vacca A; Mann RS; Frati L; Lendahl U; Gulino A; Screpanti I
Int Immunol; 1999 Jul; 11(7):1017-25. PubMed ID: 10383933
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.
Bellavia D; Campese AF; Alesse E; Vacca A; Felli MP; Balestri A; Stoppacciaro A; Tiveron C; Tatangelo L; Giovarelli M; Gaetano C; Ruco L; Hoffman ES; Hayday AC; Lendahl U; Frati L; Gulino A; Screpanti I
EMBO J; 2000 Jul; 19(13):3337-48. PubMed ID: 10880446
[TBL] [Abstract][Full Text] [Related]
13. Notch signalling at the crossroads of T cell development and leukemogenesis.
Campese AF; Bellavia D; Gulino A; Screpanti I
Semin Cell Dev Biol; 2003 Apr; 14(2):151-7. PubMed ID: 12651099
[TBL] [Abstract][Full Text] [Related]
14. Unexpected features of acute T lymphoblastic lymphomas in Notch1IC transgenic rats.
van den Brandt J; Kwon SH; McPherson KG; Petrovic S; Zettl A; Müller-Hermelink HK; Reichardt HM
Eur J Immunol; 2006 Aug; 36(8):2223-34. PubMed ID: 16838279
[TBL] [Abstract][Full Text] [Related]
15. Monoallelic
Veiga DFT; Tremblay M; Gerby B; Herblot S; Haman A; Gendron P; Lemieux S; Zúñiga-Pflücker JC; Hébert J; Cohen JP; Hoang T
Front Immunol; 2022; 13():867443. PubMed ID: 35401501
[TBL] [Abstract][Full Text] [Related]
16. Notch signalling pathway and human diseases.
Joutel A; Tournier-Lasserve E
Semin Cell Dev Biol; 1998 Dec; 9(6):619-25. PubMed ID: 10075489
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
O'Neil J; Ventura JJ; Cusson N; Kelliher M
Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
[TBL] [Abstract][Full Text] [Related]
18. A wide role for NOTCH1 signaling in acute leukemia.
Chiaramonte R; Basile A; Tassi E; Calzavara E; Cecchinato V; Rossi V; Biondi A; Comi P
Cancer Lett; 2005 Feb; 219(1):113-20. PubMed ID: 15694671
[TBL] [Abstract][Full Text] [Related]
19. Functional diversity among Notch1, Notch2, and Notch3 receptors.
Shimizu K; Chiba S; Saito T; Kumano K; Hamada Y; Hirai H
Biochem Biophys Res Commun; 2002 Mar; 291(4):775-9. PubMed ID: 11866432
[TBL] [Abstract][Full Text] [Related]
20. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.
Espinosa L; Cathelin S; D'Altri T; Trimarchi T; Statnikov A; Guiu J; Rodilla V; Inglés-Esteve J; Nomdedeu J; Bellosillo B; Besses C; Abdel-Wahab O; Kucine N; Sun SC; Song G; Mullighan CC; Levine RL; Rajewsky K; Aifantis I; Bigas A
Cancer Cell; 2010 Sep; 18(3):268-81. PubMed ID: 20832754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
